Solid Biosciences Inc.

NASDAQ: SLDB · Real-Time Price · USD
6.12
-0.05 (-0.81%)
At close: Aug 15, 2025, 3:59 PM
6.06
-0.90%
After-hours: Aug 15, 2025, 05:33 PM EDT

Solid Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-124.7M -96.02M -85.98M -72.19M
Depreciation & Amortization
2.46M 2.58M 2.41M 2.96M
Stock-Based Compensation
10.52M 7.63M 7.54M 13.37M
Other Working Capital
645K -5.57M 1.45M -12.64M
Other Non-Cash Items
8.86M -2.03M -18.25M -81K
Deferred Income Tax
n/a n/a n/a 1.21M
Change in Working Capital
2.85M -6.34M -3.69M -23.04M
Operating Cash Flow
-100.01M -94.18M -97.98M -77.76M
Capital Expenditures
-654K -1.51M -3.02M -1.28M
Cash Acquisitions
5K n/a 31.52M 89.81M
Purchase of Investments
-204.34M -117.43M -182.76M -141.25M
Sales Maturities Of Investments
188.9M 128.63M 212.81M 51.44M
Other Investing Acitivies
n/a n/a 600K -89.81M
Investing Cash Flow
-16.09M 9.69M 59.16M -91.09M
Debt Repayment
-473K n/a 2.08M n/a
Common Stock Repurchased
-5.11M n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
794K 148K 203K 107K
Financial Cash Flow
122.44M 3.12M 74.83M 134.99M
Net Cash Flow
6.34M -81.37M 36.01M -33.87M
Free Cash Flow
-100.67M -95.69M -100.99M -79.05M